Targeting CD47/SIRPĪ± as a therapeutic strategy, where we are and where we are headed
Crossref DOI link: https://doi.org/10.1186/s40364-022-00373-5
Published Online: 2022-04-13
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Qu, Tailong http://orcid.org/0000-0002-6131-6290
Li, Baiyong
Wang, Yifei
Text and Data Mining valid from 2022-04-13
Version of Record valid from 2022-04-13
Article History
Received: 12 January 2022
Accepted: 31 March 2022
First Online: 13 April 2022
Declarations
:
: This is not applicable for this review.
: Not applicable.
: The authors declare that they have no competing interests.